Polares Medical SA, a Lausanne, Switzerland-based clinical stage medical technology company, closed a $40m financing.
The round was led by Longitude Capital with the participation from Decheng Capital, Endeavour Vision, IDO Investments, Earlybird Venture Capital, and Wellington Partners.
The company intends to use the funds for the advancement of its innovative hemi-replacement technology.
Led by Jacques Essinger, Ph.D, Chairman and CEO, Polares Medical is a clinical stage medical technology company focused on the development of a trans-catheter mitral valve hemi-replacement system to treat patients suffering from mitral regurgitation (MR).
In the US, the company is based in Palo Alto, CA.